Secondary Leiomyosarcoma of the Lower Limb Following Uterine Smooth Muscle Tumor of Uncertain Malignant Potential

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Bauza, M
  • Aranda, EM
  • Valls, AR

Grupos

Abstract

INTRODUCTION: This report presents uterine smooth muscle tumors of uncertain malignant potential course with an unpredictable clinical behavior and late metastases. Metastases have been described to the humerus, lung. and peritoneum. CASE PRESENTATION: Hereby we present the case of a 71-year-old woman with a past surgical history of hysterectomy and bilateral adnexectomy due to a smooth muscle tumor of unknown malignant potential, who was evaluated 6 years later after the appearance of a mass in the proximal third of the right lower limb. The mass was diagnosed as a G1 epithelioid leiomyosarcoma and was surgically removed with immediate reconstruction with a tendinous transfer to the tibialis posterior muscle to maintain foot dorsiflexion. CONCLUSION: Patients diagnosed with smooth uterine muscle tumors of uncertain malignant potential should be closely followed up given the possibility of recurrence and late metastases, bearing in mind uncommon locations as well. such as the lower limb.

Datos de la publicación

ISSN/ISSNe:
1179-5476,

CLINICAL MEDICINE INSIGHTS-CASE REPORTS  Libertas Academica Ltd.

Tipo:
Article
Páginas:
-
PubMed:
31258342
Factor de Impacto:
0,198 SCImago
Cuartil:
Q3 SCImago

Citas Recibidas en Web of Science: 2

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • smooth muscle tumors of unknown malignant potential; leiomyosarcoma; metastases; lower extremity

Proyectos y Estudios Clínicos

RED DE INNOVACION EN TECNOLOGIAS MEDICAS Y SANITARIAS - RED ITEMAS

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

RD09/0077/00156 . INSTITUTO DE SALUD CARLOS III . 2010

INNOVATIVE APPROACH FOR SELF-MANAGEMENT AND SOCIAL WELFARE OF CYSTIC FIBROSIS PATIENTS IN EUROPE: DEVELOPMENT, VALIDATION AND IMPLEMENTATION OF A TELEMATICS TOOL. MyCyFAPP

Investigador Principal: CARMEN RIBES KONINCKX

643806_H2020-PHC-2014-single-stage-MyCyFApp . COMISION EUROPEA . 2015

MDS-RIGHT, PROVIDING THE RIGHT CARE TO THE RIGHT PATIENT WITH MYELODYSPLASTIC SYNDROME AT THE RIGHT TIME.

Investigador Principal: GUILLERMO SANZ SANTILLANA

634789 . COMISION EUROPEA . 2015

WIBEC. WIRELESS IN-BODY ENVIRONMENT COMMUNICATIONS.

Investigador Principal: VICENTE PONS BELTRÁN

675353 . COMISION EUROPEA . 2016

COBIOPHAD. COMPACT BIOPHOTONIC PLATFORM FOR DRUG ALLERGY DIAGNOSIS.

Investigador Principal: MARÍA DOLORES HERNANDEZ FERNANDEZ DE ROJAS

688448 . COMISION EUROPEA . 2016

CROWDHEALTH: COLLECTIVE WISDOM DRIVING PUBLIC HEALTH POLICIES.

Investigador Principal: BERNARDO VALDIVIESO MARTÍNEZ

727560_VALDIVIESO_SC1 . INSTITUTO GRIFOLS SA; COMISION EUROPEA . 2017

IMMUNOMETABOLOMICS. CD8+ T cell metabolism in anti-tumor response.

Investigador Principal: AGUSTÍN LAHOZ RODRÍGUEZ

751423 . COMISION EUROPEA . 2017

OACTIVE. ADVANCED PERSONALISED, MULTI-SCALE COMPUTER MODELS PREVENTING OSTEOARTHRITIS. MODELOS COMPUTACIONALES MULTIESCALA, PERSONALIZADOS Y AVANZADOS PARA LA PREVENCIÓN DE LA ARTROSIS.

Investigador Principal: ENRIQUE VIOSCA HERRERO

777159_VIOSCA_SC1 . COMISION EUROPEA . 2017

Plataforma de Innovación en Tecnologías Médicas y Sanitarias - ITEMAS

Investigador Principal: SILVIA SÁNCHEZ SALVO

PT17/0005/0011 . INSTITUTO DE SALUD CARLOS III . 2018

Cita

Compartir